Skip to main content

Table 2 Summary of MSE variation among patients with each cancer type

From: Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage

Cancer type

Mean

Min

25 percentile

Median

75 percentile

Max

Range

Number of patients

Prostate adenocarcinoma

3.88

0.04

0.24

0.42

1.21

56.14

56.10

50

Squamous cell carcinoma—head and neck

3.24

0.26

1.25

1.84

3.46

35.24

34.97

40

Hepatocellular carcinoma

4.21

0.40

1.41

2.96

6.26

19.59

19.19

49

Clear cell renal cell carcinoma

1.02

0.09

0.27

0.53

0.84

15.59

15.50

71

Esophageal adenocarcinoma

5.35

0.17

1.50

4.67

7.05

15.51

15.33

7

Aggregate carcinoma—breast

1.62

0.17

0.46

0.92

1.91

12.30

12.13

107

Ductal carcinoma—breast

1.60

0.17

0.46

0.86

1.89

12.30

12.13

85

Colorectal adenocarcinoma

1.74

0.18

0.42

0.76

1.44

11.76

11.59

46

Right colorectal adenocarcinoma

2.95

0.34

0.51

1.22

3.66

11.76

11.42

15

Duct and lobular carcinoma—breast

2.07

0.37

1.01

1.51

1.99

7.63

7.26

9

Adenocarcinoma—endometrium

1.07

0.18

0.40

0.55

1.20

7.43

7.25

23

Endometrioid adenocarcinoma

1.20

0.18

0.40

0.59

1.28

7.43

7.25

19

Cholangiocarcinoma

9.42

6.62

6.95

9.95

10.64

13.58

6.96

9

Adenocarcinoma—stomach

1.98

0.39

0.74

1.66

2.68

7.31

6.92

27

Papillary renal cell carcinoma

0.63

0.07

0.20

0.44

0.71

4.79

4.73

31

Chromophobe renal cell carcinoma

1.06

0.10

0.32

0.64

1.43

4.47

4.37

23

Aggregate transitional cell carcinoma—bladder

1.22

0.14

0.47

1.02

1.67

3.95

3.81

18

Transitional cell carcinoma—bladder

1.19

0.14

0.45

0.99

1.58

3.95

3.81

17

Adenocarcinoma—lung

1.22

0.18

0.60

1.01

1.77

3.54

3.36

51

Squamous cell carcinoma—lung

1.34

0.03

0.64

1.14

1.93

3.30

3.27

48

Bronchioloalveolar carcinoma

1.67

0.51

0.73

0.96

2.25

3.54

3.03

3

Left colorectal adenocarcinoma

0.83

0.18

0.43

0.72

1.04

2.64

2.46

18

Lobular carcinoma—breast

1.23

0.17

0.82

1.01

1.61

2.60

2.43

7

Intestinal type adenocarcinoma—stomach

1.13

0.39

0.46

0.69

1.31

2.81

2.41

5

Adenocarcinoma with mixed subtypes—lung

1.22

0.39

0.46

1.22

1.98

2.07

1.68

4

Diffuse type carcinoma—stomach

2.54

1.51

2.39

2.61

3.07

3.13

1.63

5

Papillary adenocarcinoma—lung

1.33

0.88

0.99

1.09

1.55

2.00

1.12

3

Mucinous adenocarcinoma—lung

0.78

0.23

0.71

0.94

1.01

1.04

0.81

4

Serous cystadenocarcinoma—endometrium

0.49

0.26

0.42

0.51

0.58

0.69

0.43

4

  1. This table summarizes the MSE computed for each patient with each of 29 cancer types based on codon usage. Values presented here better describe the spread of MSE values for a cancer type. Columns include “Min,” “Max,” “Range,” “Median,” and “Mean.” The number of patients examined for each cancer type is described under the “Number of patients” column; 25% and 75% refers to the first and third quartile, respectively, and may not be useful for cancer types with low patient numbers
Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us